Company intelligence
Minerva Imaging
Accelerated & Efficient Drug Development
About Minerva Imaging
Minerva Imaging is a scientifically driven CRO and CDMO specialized in targeted radionuclide therapies. The company focusses on the use of advanced models within oncology, cardiovascular diseases and in vivo molecular imaging for translational research and drug development. Minerva Imaging engages with its clients to understand their scientific questions and discuss how its methods and capabilities can provide answers. The facility located in Denmark offers best–in–industry fully integrated radiopharmaceutical research, drug development and manufacturing services.
Verified activity
Signals from Minerva Imaging
5 published signals
Research & Knowledge
Minerva Imaging scholar program student Sarah successfully defended her Master's thesis on heterogeneous responses to radiotherapy and immune checkpoint inhibition across different preclinical tumor models.
Reported by Minerva Imaging
Presence & Recognition
Minerva Imaging participated in the 45th edition of the DHL Relay in Copenhagen, which brought together over 160,000 participants from over 2,500 companies.
Reported by Minerva Imaging
Strategy & Corporate Development
Minerva Imaging General Manager, US, David Kroon will lead US commercial expansion, build the founding US team, and support strategic evaluation of a future US CDMO footprint.
Reported by Minerva Imaging
People
Minerva Imaging welcomed David Kroon as its first General Manager, US, bringing over 20 years of radiopharmaceutical experience.
Reported by Minerva Imaging
People
Minerva Imaging welcomed Signe Humle Jorgensen as Head of CRO
Reported by Minerva Imaging